Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: August 11, 2011
Last updated: February 17, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: February 17, 2016